Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fexofenadine 180mg tablets
0304010E0AAABAB
|
Fexofenadine hydrochloride | Fexofenadine hydrochloride | Respiratory System | 436,282 |
|
Fexofenadine 120mg tablets
0304010E0AAAAAA
|
Fexofenadine hydrochloride | Fexofenadine hydrochloride | Respiratory System | 331,531 |
|
Fexofenadine 30mg tablets
0304010E0AAACAC
|
Fexofenadine hydrochloride | Fexofenadine hydrochloride | Respiratory System | 26,614 |
|
Fexofenadine 180mg/5ml oral suspension
0304010E0AAAHAH
|
Fexofenadine hydrochloride | Fexofenadine hydrochloride | Respiratory System | 266 |
|
Fexofenadine 180mg/5ml oral solution
0304010E0AAAEAE
|
Fexofenadine hydrochloride | Fexofenadine hydrochloride | Respiratory System | 14 |
|
Fexofenadine 120mg/5ml oral liquid
0304010E0AAADAD
|
Fexofenadine hydrochloride | Fexofenadine hydrochloride | Respiratory System | 4 |
|
Fexofenadine 30mg/5ml oral suspension
0304010E0AAAGAG
|
Fexofenadine hydrochloride | Fexofenadine hydrochloride | Respiratory System | 1 |
|
Fexofenadine 125mg/5ml oral suspension
0304010E0AAAFAF
|
Fexofenadine hydrochloride | Fexofenadine hydrochloride | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.